The Role of Glucagon-Like Peptide-1 Receptor Agonists in Cognitive Decline and Dementia Prevention: A Systematic Review and Semiquantitative Synthesis

Dementia, particularly Alzheimer’s disease (AD), is a major global health challenge with limited treatment options. Growing evidence suggests that glucagon-like peptide-1 receptor agonists (GLP-1 RAs), originally developed for type 2 diabetes mellitus (T2DM), may offer neuroprotective benefits by im...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	Dharmendra Kumar Gupta, Arunima Chaudhuri
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	Wolters Kluwer Medknow Publications 2025-07-01
Schriftenreihe:	Journal of Mental Health and Human Behaviour
Schlagworte:	alzheimer’s disease cognitive decline dementia prevention glucagon-like peptide-1 receptor agonists neuroprotection type 2 diabetes mellitus
Online-Zugang:	https://journals.lww.com/10.4103/jmhhb.jmhhb_71_25
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!